Published in Ann Neurol on February 01, 2009
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol (2013) 4.29
The pathobiology of vascular dementia. Neuron (2013) 3.07
Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke (2011) 2.37
Fractal analysis of retinal vessels suggests that a distinct vasculopathy causes lacunar stroke. Neurology (2010) 2.04
Vascular pathology in the aged human brain. Acta Neuropathol (2010) 1.78
Blood-brain barrier permeability abnormalities in vascular cognitive impairment. Stroke (2011) 1.60
Little association between intracranial arterial stenosis and lacunar stroke. Cerebrovasc Dis (2010) 1.53
Metzincin proteases and their inhibitors: foes or friends in nervous system physiology? J Neurosci (2010) 1.41
The retina as a window to the brain-from eye research to CNS disorders. Nat Rev Neurol (2012) 1.41
Matrix metalloproteinases are associated with increased blood-brain barrier opening in vascular cognitive impairment. Stroke (2011) 1.35
Vascular complications of cystathionine β-synthase deficiency: future directions for homocysteine-to-hydrogen sulfide research. Am J Physiol Heart Circ Physiol (2010) 1.23
What are white matter hyperintensities made of? Relevance to vascular cognitive impairment. J Am Heart Assoc (2015) 1.19
The overlap between vascular disease and Alzheimer's disease--lessons from pathology. BMC Med (2014) 1.15
Enlarged perivascular spaces and cerebral small vessel disease. Int J Stroke (2013) 1.11
Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review. Neuroimage Clin (2014) 1.10
The blood-brain barrier: geriatric relevance of a critical brain-body interface. J Am Geriatr Soc (2010) 1.09
Blood-brain barrier permeability and long-term clinical and imaging outcomes in cerebral small vessel disease. Stroke (2012) 1.09
How much do focal infarcts distort white matter lesions and global cerebral atrophy measures?. Cerebrovasc Dis (2012) 1.08
White matter hyperintensities and normal-appearing white matter integrity in the aging brain. Neurobiol Aging (2014) 1.06
Hyperhomocysteinemia increases permeability of the blood-brain barrier by NMDA receptor-dependent regulation of adherens and tight junctions. Blood (2011) 1.04
Nutri-epigenetics ameliorates blood-brain barrier damage and neurodegeneration in hyperhomocysteinemia: role of folic acid. J Mol Neurosci (2014) 1.03
Vascular dementia: different forms of vessel disorders contribute to the development of dementia in the elderly brain. Exp Gerontol (2012) 1.01
Alzheimer's disease and blood-brain barrier function-Why have anti-beta-amyloid therapies failed to prevent dementia progression? Neurosci Biobehav Rev (2009) 0.97
Multimodal markers of inflammation in the subcortical ischemic vascular disease type of vascular cognitive impairment. Stroke (2014) 0.96
Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity. Nat Commun (2014) 0.94
Blood-brain barrier disruption after cardiac surgery. AJNR Am J Neuroradiol (2012) 0.93
Quantifying the effects of normal ageing on white matter structure using unsupervised tract shape modelling. Neuroimage (2010) 0.93
Lack of association of white matter lesions with ipsilateral carotid artery stenosis. Cerebrovasc Dis (2012) 0.92
Molecular biomarkers in stroke diagnosis and prognosis. Biomark Med (2009) 0.92
Pathogenesis and neuroimaging of cerebral large and small vessel disease in type 2 diabetes: A possible link between cerebral and retinal microvascular abnormalities. J Diabetes Investig (2016) 0.87
Long-Term Blood-Brain Barrier Permeability Changes in Binswanger Disease. Stroke (2015) 0.87
Higher ambulatory blood pressure relates to enlarged Virchow-Robin spaces in first-ever lacunar stroke patients. J Neurol (2012) 0.86
Cardiovascular risk factors for acute stroke: Risk profiles in the different subtypes of ischemic stroke. World J Clin Cases (2015) 0.85
The mechanisms of cerebral vascular dysfunction and neuroinflammation by MMP-mediated degradation of VEGFR-2 in alcohol ingestion. Arterioscler Thromb Vasc Biol (2012) 0.85
A comparison of location of acute symptomatic vs. 'silent' small vessel lesions. Int J Stroke (2015) 0.84
Integrity of normal-appearing white matter: Influence of age, visible lesion burden and hypertension in patients with small-vessel disease. J Cereb Blood Flow Metab (2016) 0.84
Consensus statement for diagnosis of subcortical small vessel disease. J Cereb Blood Flow Metab (2016) 0.84
Opening of the blood-brain barrier before cerebral pathology in mild hyperhomocysteinemia. PLoS One (2013) 0.83
Myelin basic protein autoantibodies, white matter disease and stroke outcome. J Neuroimmunol (2012) 0.83
Neuroinflammation and cerebrovascular disease in old age: a translational medicine perspective. J Aging Res (2011) 0.83
Frontal white matter hyperintensities, clasmatodendrosis and gliovascular abnormalities in ageing and post-stroke dementia. Brain (2015) 0.83
Microvascular pathology and morphometrics of sporadic and hereditary small vessel diseases of the brain. Brain Pathol (2014) 0.82
Rationale, design and methodology of the image analysis protocol for studies of patients with cerebral small vessel disease and mild stroke. Brain Behav (2015) 0.82
Development and initial evaluation of a semi-automatic approach to assess perivascular spaces on conventional magnetic resonance images. J Neurosci Methods (2015) 0.81
Methylophiopogonanone A Protects against Cerebral Ischemia/Reperfusion Injury and Attenuates Blood-Brain Barrier Disruption In Vitro. PLoS One (2015) 0.81
Validation of biomarkers in subcortical ischaemic vascular disease of the Binswanger type: approach to targeted treatment trials. J Neurol Neurosurg Psychiatry (2015) 0.80
Blood-brain barrier dysfunction and cerebral small vessel disease (arteriolosclerosis) in brains of older people. J Neuropathol Exp Neurol (2014) 0.79
Comparison of cerebral blood flow and structural penumbras in relation to white matter hyperintensities: A multi-modal magnetic resonance imaging study. J Cereb Blood Flow Metab (2016) 0.79
Binswanger's disease: toward a diagnosis agreement and therapeutic approach. Expert Rev Neurother (2014) 0.78
On the computational assessment of white matter hyperintensity progression: difficulties in method selection and bias field correction performance on images with significant white matter pathology. Neuroradiology (2016) 0.78
Risk factors of dilated Virchow-Robin spaces are different in various brain regions. PLoS One (2014) 0.77
Association between Perivascular Spaces and Progression of White Matter Hyperintensities in Lacunar Stroke Patients. PLoS One (2015) 0.77
Pericytes contribute to the disruption of the cerebral endothelial barrier via increasing VEGF expression: implications for stroke. PLoS One (2015) 0.77
Genetic Associations With White Matter Hyperintensities Confer Risk of Lacunar Stroke. Stroke (2016) 0.76
Plasma Biomarkers of Inflammation, Endothelial Function and Hemostasis in Cerebral Small Vessel Disease. Cerebrovasc Dis (2015) 0.76
Silencing microRNA-143 protects the integrity of the blood-brain barrier: implications for methamphetamine abuse. Sci Rep (2016) 0.75
Interhemispheric characterization of small vessel disease imaging markers after subcortical infarct. Brain Behav (2016) 0.75
The Relationship between Cerebral Small Vessel Disease, Hippocampal Volume and Cognitive Functioning in Patients with COPD: An MRI Study. Front Aging Neurosci (2017) 0.75
Endothelial Function, Inflammation, Thrombosis, and Basal Ganglia Perivascular Spaces in Patients with Stroke. J Stroke Cerebrovasc Dis (2016) 0.75
Ischemic stroke: experimental models and reality. Acta Neuropathol (2017) 0.75
Temporal changes in blood-brain barrier permeability and cerebral perfusion in lacunar/subcortical ischemic stroke. BMC Neurol (2015) 0.75
Enlarged perivascular spaces are associated with the disease activity in systemic lupus erythematosus. Sci Rep (2017) 0.75
Application of Texture Analysis to Study Small Vessel Disease and Blood-Brain Barrier Integrity. Front Neurol (2017) 0.75
T1 hyperintensity on brain imaging subsequent to gadolinium-based contrast agent administration: what do we know about intracranial gadolinium deposition? Br J Radiol (2016) 0.75
Update on cerebral small vessel disease: a dynamic whole-brain disease. Stroke Vasc Neurol (2016) 0.75
Higher blood-brain barrier permeability is associated with higher white matter hyperintensities burden. J Neurol (2017) 0.75
Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med (2007) 6.47
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol (2013) 6.18
Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol (2012) 3.93
Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81
Early supported discharge services for stroke patients: a meta-analysis of individual patients' data. Lancet (2005) 3.56
Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat (2005) 3.02
Predicting outcome after acute and subacute stroke: development and validation of new prognostic models. Stroke (2002) 2.83
Retinal image analysis: concepts, applications and potential. Prog Retin Eye Res (2005) 2.49
Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts. Stroke (2005) 2.43
Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies. BMJ (2008) 2.43
Stroke. Lancet (2003) 2.40
improving interrater agreement about brain microbleeds: development of the Brain Observer MicroBleed Scale (BOMBS). Stroke (2008) 2.09
Do acute phase markers explain body temperature and brain temperature after ischemic stroke? Neurology (2012) 2.03
Cataract surgery and consent; recall, anxiety, and attitude toward trainee surgeons preoperatively and postoperatively. J Cataract Refract Surg (2004) 1.91
Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs. Stroke (2004) 1.91
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
Meta-analysis in more than 17,900 cases of ischemic stroke reveals a novel association at 12q24.12. Neurology (2014) 1.85
Use of Nd:YAG laser capsulotomy. Surv Ophthalmol (2003) 1.82
Common variants at 6p21.1 are associated with large artery atherosclerotic stroke. Nat Genet (2012) 1.81
Stroke Genetics Network (SiGN) study: design and rationale for a genome-wide association study of ischemic stroke subtypes. Stroke (2013) 1.80
Mutation in a short-chain collagen gene, CTRP5, results in extracellular deposit formation in late-onset retinal degeneration: a genetic model for age-related macular degeneration. Hum Mol Genet (2003) 1.79
Third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke. Trials (2008) 1.79
Diffusion-weighted imaging and diagnosis of transient ischemic attack. Ann Neurol (2014) 1.72
White matter abnormalities in bipolar disorder and schizophrenia detected using diffusion tensor magnetic resonance imaging. Bipolar Disord (2009) 1.71
Genetic heritability of ischemic stroke and the contribution of previously reported candidate gene and genomewide associations. Stroke (2012) 1.68
A general factor of brain white matter integrity predicts information processing speed in healthy older people. J Neurosci (2010) 1.67
A systematic review of the utility of 1.5 versus 3 Tesla magnetic resonance brain imaging in clinical practice and research. Eur Radiol (2012) 1.64
Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS Med (2009) 1.63
Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials. Lancet Neurol (2013) 1.62
Clonal analysis of patterns of growth, stem cell activity, and cell movement during the development and maintenance of the murine corneal epithelium. Dev Dyn (2002) 1.59
White matter tractography in bipolar disorder and schizophrenia. Biol Psychiatry (2008) 1.58
Retinopathy in ischemic stroke subtypes. Stroke (2008) 1.54
Little association between intracranial arterial stenosis and lacunar stroke. Cerebrovasc Dis (2010) 1.53
Blood biomarkers for the diagnosis of acute cerebrovascular diseases: a prospective cohort study. Cerebrovasc Dis (2011) 1.53
Effects of introducing an integrated care pathway in an acute stroke unit. Age Ageing (2004) 1.52
Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants. Stroke (2013) 1.51
Safety and efficacy of a dexamethasone anterior segment drug delivery system in patients after phacoemulsification. J Cataract Refract Surg (2004) 1.50
Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited. Trials (2011) 1.49
Corneal abnormalities in Pax6+/- small eye mice mimic human aniridia-related keratopathy. Invest Ophthalmol Vis Sci (2003) 1.48
Effect of axial length on retinal vascular network geometry. Am J Ophthalmol (2005) 1.46
An open source toolkit for medical imaging de-identification. Eur Radiol (2010) 1.42
Carotid artery imaging for secondary stroke prevention: both imaging modality and rapid access to imaging are important. Stroke (2009) 1.40
Comparing risks of death and recurrent vascular events between lacunar and non-lacunar infarction. Brain (2005) 1.36
A systematic review of brain metabolite changes, measured with 1H magnetic resonance spectroscopy, in healthy aging. Neurobiol Aging (2007) 1.35
Ischemic stroke is associated with the ABO locus: the EuroCLOT study. Ann Neurol (2013) 1.30
Potential animal models of lacunar stroke: a systematic review. Stroke (2009) 1.28
Blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-lacunar stroke and non-stroke: systematic review and meta-analysis. Cerebrovasc Dis (2013) 1.28
UK biobank data: come and get it. Sci Transl Med (2014) 1.25
Neuroprotective lifestyles and the aging brain: activity, atrophy, and white matter integrity. Neurology (2012) 1.24
Close correlation between quantitative and qualitative assessments of white matter lesions. Neuroepidemiology (2012) 1.22
Changes in background blood-brain barrier integrity between lacunar and cortical ischemic stroke subtypes. Stroke (2008) 1.22
NMDA receptor autoantibodies in sporadic Creutzfeldt-Jakob disease. J Neurol (2012) 1.21
The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke. Stroke (2011) 1.19
Genome-wide association study of age-related macular degeneration identifies associated variants in the TNXB-FKBPL-NOTCH4 region of chromosome 6p21.3. Hum Mol Genet (2012) 1.18
Interventions for visual field defects in patients with stroke. Cochrane Database Syst Rev (2011) 1.15
Increased apoptosis and abnormal wound-healing responses in the heterozygous Pax6+/- mouse cornea. Invest Ophthalmol Vis Sci (2006) 1.15
Complement factor D in age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 1.14
Measurement of regional brain temperature using proton spectroscopic imaging: validation and application to acute ischemic stroke. Magn Reson Imaging (2006) 1.14
Predictors of adherence to secondary preventive medication in stroke patients. Ann Behav Med (2011) 1.13
Blood-brain barrier permeability in Alzheimer's disease: a case-control MRI study. Psychiatry Res (2009) 1.10
Cataract surgery in patients with age-related macular degeneration: one-year outcomes. J Cataract Refract Surg (2003) 1.10
Improving adherence to medication in stroke survivors: a pilot randomised controlled trial. Ann Behav Med (2013) 1.09
How much do focal infarcts distort white matter lesions and global cerebral atrophy measures?. Cerebrovasc Dis (2012) 1.08
Stroke liaison workers for stroke patients and carers: an individual patient data meta-analysis. Cochrane Database Syst Rev (2010) 1.06
ABCD2 score and secondary stroke prevention: Meta-analysis and effect per 1,000 patients triaged. Neurology (2016) 1.06
Adherence to medication in stroke survivors: a qualitative comparison of low and high adherers. Br J Health Psychol (2010) 1.06
Brain atrophy associations with white matter lesions in the ageing brain: the Lothian Birth Cohort 1936. Eur Radiol (2012) 1.05
17q25 Locus is associated with white matter hyperintensity volume in ischemic stroke, but not with lacunar stroke status. Stroke (2013) 1.04
Interventions for post-stroke fatigue. Cochrane Database Syst Rev (2009) 1.04
Developmental and cellular factors underlying corneal epithelial dysgenesis in the Pax6+/- mouse model of aniridia. Exp Eye Res (2005) 1.03
Door-to-needle time and the proportion of patients receiving intravenous thrombolysis in acute ischemic stroke: uniform interpretation and reporting. Stroke (2013) 1.01
Variations in quality indicators of acute stroke care in 6 European countries: the European Implementation Score (EIS) Collaboration. Stroke (2011) 1.01
Multilocus genetic risk score associates with ischemic stroke in case-control and prospective cohort studies. Stroke (2014) 0.99
Associations of clinical stroke misclassification ('clinical-imaging dissociation') in acute ischemic stroke. Cerebrovasc Dis (2010) 0.99
Long anterior lens zonules in late-onset retinal degeneration (L-ORD). Am J Ophthalmol (2005) 0.99
Dehydration in hospital-admitted stroke patients: detection, frequency, and association. Stroke (2011) 0.99
Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration. Hum Mol Genet (2013) 0.97
Unidentified foreign objects in the wound after clear corneal tunnel phacoemulsification. J Cataract Refract Surg (2002) 0.96
No evidence of association between complement factor I genetic variant rs10033900 and age-related macular degeneration. Eur J Hum Genet (2011) 0.94
Predicting functional outcome after stroke by modelling baseline clinical and CT variables. Age Ageing (2010) 0.94
MR diffusion and perfusion parameters: relationship to metabolites in acute ischaemic stroke. J Neurol Neurosurg Psychiatry (2009) 0.94
Quantifying the effects of normal ageing on white matter structure using unsupervised tract shape modelling. Neuroimage (2010) 0.93
Posterior capsule morphology determinants of visual function. Graefes Arch Clin Exp Ophthalmol (2003) 0.92